Ocriplasmin opens up new avenues in the therapy of vitreomacular traction
2013
Until now, the only treatment available for severe symptomatic vitreomacular traction, has been pars-plana-vitrectomy. Now, there is evidence for a new minimally invasive surgical therapy: the results of two Phase III studies show that an intravitreal injection of ocriplasmin allows an enzymatic vitreolysis.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
26
References
0
Citations
NaN
KQI